You are here
News
Genome Canada named National Capital Region Top Employer
Tuesday, February 2, 2021
As Genome Canada continues its leading role in Canada’s COVID-19 public health response, the organization has been named a 2021 Top
Updated statement on CanCOGeN and SARS-CoV-2 variants of concern
Monday, January 18, 2021
(This statement is an updated version of our original statement of Dec. 22, 2020 when the first new variant was identified in the United Kingdom.)
New genomics research investments to tackle health challenges and a resilient recovery for Canada
Monday, October 26, 2020
$16 million in federal funding to support new genomics research in health, agriculture and the environment
As Canada addresses ongoing challenges posed by the COVID-19 pandemic and charts a course for economic recovery, harnessing the game-changing potential of genomics can deliver homegrown solutions and help protect and improve Canadian lives.
Genome Canada welcomes two new Board members
Thursday, June 25, 2020
Drs. Elizabeth Douville (Chair of the Board of Directors) and Rob Annan (President and CEO) are pleased to announce the appointment of Dr. Bonnie Schmidt and Mr. Andrew Stephens to Genome Canada’s Board of Directors for two-year terms. Dr. Douville and existing Board members Mr. Eric Cook and Dr. Jacques Simoneau were reappointed for additional two-year terms.
New Executive Director, CanCOGeN
Monday, June 22, 2020
Genome Canada is pleased to welcome Dr. Catalina Lopez-Correa as Executive Director, Canadian COVID Genomics Network (CanCOGeN), effective June 22, 2020.
Fourteen AI research projects join the fight against COVID-19
Tuesday, May 12, 2020
Projects include machine learning research and applications to identify potential treatments, to support public health measures such as social distancing, and to better understand the viral transmission of COVID-19.
Fourteen new AI research projects will be launched to address the COVID-19 outbreak through CIFAR’s AI and COVID-19 Catalyst Grants initiative.